A four-year nationwide molecular epidemiological study in Estonia: risk factors for tuberculosis transmission
Objective: To use 24-locus variable numbers of tandem repeat (VNTR) typing and national TB registry data in Estonia from 2009 to 2012 to identify the distribution of drug resistance patterns, Mycobacterium tuberculosis isolate clustering as an index for recent transmission, socio-demographic and clinical characteristics associated with recent transmission, and the distribution of transmission between index and secondary cases.
Design: A retrospective nationwide cross-sectional study.
Results: Of 912 cases with isolate and patient information, 39.1% of isolates were from the Beijing lineage. Cluster analysis identified 87 clusters encompassing 69.1% of isolates. The largest cluster comprised 178 isolates from the Beijing lineage, of which 92.1% were MDR- or extensively drug-resistant TB (XDR-TB). Factors associated with recent transmission were polyresistant TB, MDR- and XDR-TB, human immunodeficiency virus positivity, Russian ethnicity, non-permanent living situation, alcohol abuse and detention. XDR-TB cases had the highest risk of recent transmission. The majority of transmission cases involved individuals aged 30–39 years.
Conclusion: Recent TB transmission in Estonia is high and is particularly associated with MDR- and XDR-TB and the Beijing lineage.
Keywords: Beijing lineage; MDR-TB; SORT IT; clustering; operational research
Document Type: Research Article
Affiliations: 1: United Laboratories, Tartu University Hospital, Tartu, Estonia, Department of Pulmonary Medicine, University of Tartu, Tartu, Estonia 2: Department of Pulmonary Medicine, University of Tartu, Tartu, Estonia, Lung Clinic, Tartu University Hospital, Tartu, Estonia 3: Tuberculosis and M/ XDR-TB Programme, Division of Communicable Diseases, Health Security & Environment, World Health Organization Regional Office for Europe, Copenhagen, Denmark 4: National Institute for Health Development, Tallinn, Estonia 5: Tuberculosis and M/ XDR-TB Programme, Division of Communicable Diseases, Health Security & Environment, World Health Organization Regional Office for Europe, Copenhagen, Denmark, Centre for Infectious Diseases Control, National Institute of Public Health and the Environment, Bilthoven, The Netherlands 6: United Laboratories, Tartu University Hospital, Tartu, Estonia 7: Lung Clinic, Tartu University Hospital, Tartu, Estonia 8: Medical Department, Brussels Operational Center, Médecins Sans Frontières MSF-Luxembourg, Luxembourg 9: International Union Against Tuberculosis and Lung Disease, Paris, France, London School of Hygiene & Tropical Medicine, London, UK 10: Institut National de la Santé et de la Recherche Médicale 1019, Lille, France, Unités Mixtes de Recherche 8204, Centre national de la Recherche scientifique, Lille, France, Center for Infection and Immunity of Lille, Institut Pasteur de Lille, Lille, France, University Nord de France, Lille, France
Publication date: 21 October 2014
Public Health Action (PHA), The Union's quarterly Open Access journal, welcomes the submission of articles on operational research. It publishes high-quality scientific research on health services, providing new knowledge on how to improve access, equity, quality and efficiency of health systems and services.
The Editors will consider any manuscript reporting original research on quality improvements, cost-benefit analysis, legislation, training and capacity building, with a focus on all relevant areas of public health (e.g. infection control, nutrition, TB, HIV, vaccines, smoking, COVID-19, microbial resistance, outbreaks etc).
- Editorial Board
- Information for Authors
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites
Receive new issue alert- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content